Skip to main content

Market Overview

8 Biggest Mid-Day Gainers For Monday

Share:

Overseas Shipholding Group, Inc. Class A (NYSE: OSG) shares jumped 470.53 percent to $10.84.

GlobeImmune Inc (NASDAQ: GBIM) shares surged 90.90 percent to $2.31.

LinkedIn Corp (NYSE: LNKD) shares climbed 46.93 percent to $192.60 after Microsoft Corporation (NASDAQ: MSFT) announced plans to acquire LinkedIn for $196 per share.

Eleven Biotherapeutics Inc (NASDAQ: EBIO) shares jumped 44.65 percent to $2.70 as the company reported that that it has submitted an Investigational New Drug application to the FDA to initiate a Phase 1 clinical trial of EBI-031 for ocular diseases. The company announced the signing of exclusive license agreement with Roche covering IL-6 antagonist antibody.

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares surged 9.82 percent to $0.681 after the company reported an agreement with the FDA on confirmatory Phase 3 study protocol for Firdapse in Lambert-Eaton myasthenic syndrome.

Sturm, Ruger & Company (NYSE: RGR) shares gained 9.74 percent to $62.97 following Orlando shootings on Sunday.

Smith & Wesson Holding Corp (NASDAQ: SWHC) gained 7.43 percent to $23.00 following Orlando shootings on Sunday. Gun stocks, including Smith & Wesson, were trading higher as the shooting could result in a surge of gun sales to individuals looking to protect themselves.

Science Applications International Corp (NYSE: SAIC) shares rose 4.52 percent to $59.91. SAIC reported better-than-expected results for its first quarter.

 

Related Articles (OSG + GBIM)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com